| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/20/2000 | CA2359678A1 Use of s-triazines for treating apicomplexan parasitic infections |
| 07/20/2000 | CA2359461A1 Inhibiting development of microvessels within vascular walls |
| 07/20/2000 | CA2359392A1 Use of apoptosis inducing agents in the treatment of (auto)immune diseases |
| 07/20/2000 | CA2359335A1 Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
| 07/20/2000 | CA2359273A1 Pharmaceutical formulations containing an opioid and an .alpha.-agonist |
| 07/20/2000 | CA2359110A1 Combination of hepatitis b vaccine with antiviral agents |
| 07/20/2000 | CA2358748A1 Reagents and methods useful for detecting diseases of the breast |
| 07/20/2000 | CA2358684A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/20/2000 | CA2356939A1 Modulation of systemic memory t cell trafficking |
| 07/20/2000 | CA2356440A1 New dialysis method |
| 07/20/2000 | CA2355374A1 1-heterocycle substituted diarylamines |
| 07/20/2000 | CA2353088A1 Bis-amino acid sulfonamides containing n-terminally a substituted benzyl group as hiv protease inhibitors |
| 07/20/2000 | CA2349467A1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors |
| 07/20/2000 | CA2349180A1 Anthranilic acid derivatives |
| 07/20/2000 | CA2348236A1 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors |
| 07/19/2000 | EP1020193A1 Oral preparation |
| 07/19/2000 | EP1020190A2 Treatment of BPH with cGMP elevators |
| 07/19/2000 | EP1020185A2 Opioid analgesics with controlled release |
| 07/19/2000 | EP1020183A2 Analgesic composition with controlled release |
| 07/19/2000 | EP1019802A2 Method and system for pain management |
| 07/19/2000 | EP1019716A1 Methods for screening drugs to predict tardive dyskinesia |
| 07/19/2000 | EP1019529A1 A method of treating cancer |
| 07/19/2000 | EP1019513A1 Ikr-1 and ikr-2, protein kinases which are related to the i kappa b kinases |
| 07/19/2000 | EP1019490A2 Methods for modulating hematopoiesis and vascular growth |
| 07/19/2000 | EP1019432A1 The ob receptor and methods of diagnosing and treating weight |
| 07/19/2000 | EP1019431A1 Novel rnase p |
| 07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019096A2 Bioresorbable compositions for implantable prostheses |
| 07/19/2000 | EP1019092A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| 07/19/2000 | EP1019088A1 Composition for the treatment of nicotine addiction containing a nicotine receptor antagonist and an anti-depressant or anti-anxiety drug |
| 07/19/2000 | EP1019087A1 Ganglioside immunostimulating complexes and uses thereof |
| 07/19/2000 | EP1019082A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 07/19/2000 | EP1019081A2 Apolipoprotein e/growth factor complexes and methods of use |
| 07/19/2000 | EP1019080A2 Modulation of lerk-2-mediated cell adhesion |
| 07/19/2000 | EP1019076A1 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents |
| 07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019072A1 Method for assisting in differential diagnosis and treatment of autistic syndromes |
| 07/19/2000 | EP1019069A2 Novel methods for testing inhibitors of paired helical filaments and uses for treatment of alzheimer's disease |
| 07/19/2000 | EP1019066A1 Methods and compositions for preventing and treating heartburn |
| 07/19/2000 | EP1019065A1 Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications |
| 07/19/2000 | EP1019059A1 USE OF FXR, PPARalpha AND LXRalpha ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION |
| 07/19/2000 | EP1019057A1 A method of preventing or treating estrogen-dependent diseases and disorders |
| 07/19/2000 | EP1019056A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89 |
| 07/19/2000 | EP1019055A1 Endothelin antagonist and beta receptor blocking agent as combined preparations |
| 07/19/2000 | EP1019050A1 Use of somatostatin agonists and antagonists for treating diseases related to the eye |
| 07/19/2000 | EP1019049A1 Methods and compositions for treating and/or preventing non-insulin dependent diabetes mellitus (niddm) using specific retinoid compounds |
| 07/19/2000 | EP1019044A1 Composition and methods for treating alzheimer's disease and other amyloidoses |
| 07/19/2000 | EP1019043A1 Inhibitors of glycogen synthase kinase-3 and methods for identifying and using the same |
| 07/19/2000 | EP1019041A1 Method of improving disturbed behavior and elevating mood in humans |
| 07/19/2000 | EP1019036A1 Use of d-methionine to reduce the toxicity of ototoxic drugs, noise, and radiation |
| 07/19/2000 | EP1019034A2 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 07/19/2000 | EP1019023A1 Stabilized preparations for use in nebulizers |
| 07/19/2000 | EP1019022A1 Perforated microparticles and methods of use |
| 07/19/2000 | EP1019021A1 Stabilized preparations for use in metered dose inhalers |
| 07/19/2000 | EP1019020A1 Stabilized bioactive preparations and methods of use |
| 07/19/2000 | EP0735877B1 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists |
| 07/19/2000 | EP0722320B1 Use of nitric oxide-releasing compounds as medicaments for hypoxic cell radiation sensitization |
| 07/19/2000 | EP0573565B1 Opiate receptor antagonist modulates hyperkinetic movement disorder |
| 07/19/2000 | EP0514452B2 Use of insulin sensitizing agents to treat hypertension |
| 07/19/2000 | CN1260719A Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 07/19/2000 | CN1260716A Treatment of diabetes with thiazolidinedione and metformin |
| 07/19/2000 | CN1260703A Drug delivery device and method for treating viral and microbial infections and wasting syndromes |
| 07/19/2000 | CN1054509C Synergistic interplay of lymphokines and dsRNAs |
| 07/18/2000 | US6090944 Alkanoic acid derivatives as αv integrin receptor antagonists |
| 07/18/2000 | US6090839 Antidiabetic agents |
| 07/18/2000 | US6090836 Benzisoxazole-derived antidiabetic compounds |
| 07/18/2000 | US6090833 Polycyclic dihydrothiazoles, their preparation, and use as pharmaceuticals |
| 07/18/2000 | US6090825 Oxazole derivatives as antagonists of alpha 1C andrenergic receptors |
| 07/18/2000 | US6090819 Use of NK-1 receptor antagonists for treating mania |
| 07/18/2000 | US6090796 Anticancer, antitumor agent; viricide |
| 07/18/2000 | US6090794 Inhibition of neurofibrosarcoma growth and angiogenesis |
| 07/18/2000 | US6090782 Contacting hematopoietic cells with a stem cell proliferation inhibition amount of a peptide or polypeptide having specific amino acid sequence |
| 07/18/2000 | US6090612 Polynucleotide sequence coding a phosphatase enzymes; a diagnostic tool for monitoring enzyme activity in sample; for treatment of nervous system disorders, cardiovascular disorders and tumors; antitumor agents |
| 07/18/2000 | US6090579 Human SDR2 cDNA clone |
| 07/18/2000 | US6090564 Amino acid sequence of human small nuclear ribonucleoprotein protein; for diagnosis, prevention and treatment of systemic lupus erythematosus |
| 07/18/2000 | US6090544 Screening for compounds capable of activating osteogenic protein-1-responsive transcription activating element by transforming cell with dna of element linked to reporter gene, exposing cell to compound, determining gene expression |
| 07/18/2000 | US6090412 Solid drug |
| 07/18/2000 | US6090407 Administering anticancer drug to respiratory system |
| 07/18/2000 | CA2295471A1 Opioid analgesics with controlled active substance release |
| 07/18/2000 | CA2295469A1 Analgesic with controlled active substance release |
| 07/18/2000 | CA2183954C Treatment of obsessive-compulsive disorders with 5-ht2 antagonists |
| 07/18/2000 | CA2148651C Halogenated antifungal and antibacterial compounds used for reducing hair loss |
| 07/18/2000 | CA2129051C Absorbable composite materials for use in the treatment of periodontal disease |
| 07/18/2000 | CA2017376C Diarylstyrylquinoline diacids |
| 07/18/2000 | CA2014714C A method of preparing a freeze-dried formulation containing a drug |
| 07/13/2000 | WO2000040733A1 Human cyclic nucleotide pdes |
| 07/13/2000 | WO2000040701A2 Non-myeloablative tolerogenic treatment |
| 07/13/2000 | WO2000040614A2 Characterization of the soc/crac calcium channel protein family |
| 07/13/2000 | WO2000040613A1 Insulin-like growth factor (igf) i mutant variants |
| 07/13/2000 | WO2000040597A1 Method and composition for angiogenesis inhibition |
| 07/13/2000 | WO2000040595A1 Antisense modulation of novel anti-apoptotic bcl-2-related proteins |
| 07/13/2000 | WO2000040269A2 Pharmaceutical compositions for treatment of diseased tissues |
| 07/13/2000 | WO2000040268A1 Antitumor agents |
| 07/13/2000 | WO2000040265A1 Potentiation of anti-cd38-immunotoxin cytotoxicity |
| 07/13/2000 | WO2000040252A1 Novel polymer formulations containing perfluorinated compounds for the engineering of cells and tissues for transplantation that improves cell metabolism and survival, and methods for making same |
| 07/13/2000 | WO2000040241A2 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 07/13/2000 | WO2000040237A1 Antiviral method using mek inhibitors |
| 07/13/2000 | WO2000040235A2 Treatment of asthma with mek inhibitors |
| 07/13/2000 | WO2000040232A2 Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions |
| 07/13/2000 | WO2000040229A2 Synergistic tumorcidal response induced by histamine |